Jamjoom Pharmaceuticals Holds Extraordinary General Assembly Meeting
JAMJOOM PHARMA 4015.SA | 0.00 |
On June 16, 2026, Jamjoom Pharmaceuticals Factory Co. announced the results of its Extraordinary General Assembly meeting held on June 15, 2026, at 20:30 at the company's headquarters in Jeddah via the Tadawulaty system. The meeting achieved a quorum with 85.0% shareholder attendance and was attended by eight of nine Board of Directors members, with only Mr. Noor Ahmed Kather Pasha Sheriff unable to attend. Committee chairmen including Mr. Faris Ibrahim Abdullah Al Ghannam (Audit Committee), Mrs. Rania Sami Al-Turki (Nomination and Remuneration Committee), and Mr. Benjamin Richard Toogood (Executive Committee) were present at the meeting.
Original announcement:
https://www.saudiexchange.sa/wps/portal/saudiexchange/newsandreports/issuer-news/issuer-announcements/issuer-announcements-details/?anId=96112&anCat=1&cs=4015&locale=arAttached PDF document link:
https://www.saudiexchange.sa/Resources/fsPdf/19413_4526_2026-06-15_21-42-14_en.pdfNote: The original announcement does not explicitly specify a currency unit. Figures above are reproduced as-is. Please refer to the original announcement for details.
Important Notice: The announcement information and market data in this report are sourced directly from the Saudi Exchange (Tadawul). This summary is generated by Sahm’s proprietary AI model for informational purposes only. While we strive for accuracy, it should not be construed as financial advice or an investment recommendation.